We extract valuable insights from standard DNA and RNA tumor sequencing reports, offering you actionable tumoral data and clinical recommendations. As a dedicated team of oncologists and AI experts, we’ve trained our AI to extract unrecognized biological insights, mutational signatures, personalized mutations ranking, responses to immunotherapy and vital drug resistance information. We process your patient's DNA sequencing report through our AI engine, delivering integrated, reasoned clinical recommendations that you can immediately apply in your practice. Contact us now for more details.
Our AI platform excels in patient stratification, helping companies identify specific subgroups based on deep genomic profiling and clinical characteristics, which extraordinarily enhances the effectiveness of Phase 3 clinical trials. Additionally, our AI engine supports drug repurposing, leveraging novel biomarkers and resistance patterns. Contact us to explore how we can help you design more efficient, precision-driven clinical trials and accelerate your cancer-related drug development.
Copyright © 2024 GenoCure.AI Ltd - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.